Physician profile
Darian E Wilson
NPI 1699392761
$12,884.32
in general payments reported to CMS, 2019-2025
33 companies · $1,641 in 2025
The $1,641 reported for 2025 was more than what 87% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $51.73 · 2021: $635 · 2022: $4,766 · 2023: $1,979 · 2024: $3,812 · 2025: $1,641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,762 · Travel and Lodging: $2,670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,761.68 |
| Travel and Lodging | $2,669.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,623.83 | 2021-2025 | Prostep, Citrefix, Bioskin |
| Novus Surgical Solutions LLC | $1,546.96 | 2022 | |
| Treace Medical Concepts, INC. | $1,066.46 | 2025 | |
| Linvatec Corporation | $950.18 | 2024 | Quantum, Biobrace 23mm |
| Medical Device Business Services, INC. | $475.71 | 2023 | |
| Integra Lifesciences Corporation | $441.13 | 2021-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kerecis Limited | $286.06 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Musculoskeletal Transplant Foundation INC. | $269.41 | 2021-2023 | |
| Novus Surgical Consultants | $260.89 | 2023-2025 | |
| Organogenesis INC. | $228.05 | 2022-2023 | Puraply |
| Abbvie INC. | $174.44 | 2023-2025 | Dalvance |
| Paratek Pharmaceuticals, INC. | $153.59 | 2022-2025 | Nuzyra |
| Aroa Biosurgery Incorporated | $140.60 | 2023 | |
| International Life Sciences | $128.19 | 2024 | Flexband |
| Convatec INC. | $124.00 | 2023 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $124.00 | 2022 | |
| Bioventus LLC | $122.90 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Paragon 28, INC. | $104.48 | 2025 | Ttc Nail |
| Boston Scientific Corporation | $89.35 | 2022 | |
| Smith+Nephew, INC. | $72.15 | 2024-2025 | Grafix Pl, Renasys Touch, Stravix Pl |
| Depuy Synthes Sales INC. | $62.03 | 2025 | Motoband |
| Urgo Medical North America, LLC | $59.69 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Trilliant Surgical LLC. | $51.73 | 2020 | |
| Advanced Oxygen Therapy INC. | $47.75 | 2024-2025 | Topical Oxygen Chamber For Extremities |
| Orthofix Medical, INC. | $42.93 | 2024-2025 | Physio-Stim |
| Solventum Corporation | $42.48 | 2025 | V.A.C.Instill, Prevena |
| Averitas Pharma INC. | $37.96 | 2024 | Qutenza |
| Abbott Laboratories | $33.25 | 2025 | Proclaim |
| Fusion Orthopedics USA, LLC | $29.97 | 2023-2025 | |
| Impactortho, INC. | $29.00 | 2024 | |
| Flower Orthopedics Coporation | $27.03 | 2025 | |
| Innovation Technologies INC | $20.77 | 2024 | Irrisept |
| Biocomposites INC | $17.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darian Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.